HRTX - HERON THERAPEUTICS, INC. /DE/

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 2.77

Open

$ 3.04

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.72 - $ 3.04

52 Week Range

$ 0.50 - $ 3.22

Volume

1,992,410

Average Volume

Market Cap

418.82M

Beta (5Y Monthly)

$ 1.42

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-12-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-29-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-03-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-05-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-22-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-06-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	02-23-2017	12-31-2016	10-K
31	11-08-2016	09-30-2016	10-Q
32	08-08-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	02-19-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	03-13-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-04-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Heron Therapeuti...
05/08/2024 09:35:35

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

Heron Therapeutics shares are trading high...
05/07/2024 12:18:33

Heron Therapeutics Reaffirms FY24 Revenue ...
05/07/2024 12:03:19

Heron Therapeutics Q1 2024 GAAP EPS $(0.02...
05/07/2024 12:02:10

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(...

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

healthstream-reports-upbeat-results-joins-spotify-ryder-system-and-other-big-stocks-moving-higher-on-tuesday

HealthStream Reports Upbeat Results, Joins...
04/23/2024 14:50:19

Capital One Initiates Coverage On Heron Th...
04/23/2024 11:14:11

Capital One analyst Tim Chiang initiates coverage on Heron Therapeutics (NASDAQ:HRTX) with a Overweight rating and announces...

Needham Reiterates Buy on Heron Therapeuti...
04/11/2024 10:02:04

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

why-is-postoperative-pain-focused-heron-therapeutics-stock-trading-higher-on-wednesday

Why Is Postoperative Pain Focused Heron Th...
03/13/2024 18:41:24

Heron Therapeutics' Q4 2023 results: Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in ac...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
03/13/2024 17:31:16

why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Clover Health Investments Shares Are T...
03/13/2024 17:18:56

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

Needham Maintains Buy on Heron Therapeutic...
03/13/2024 10:28:03

Needham analyst Serge Belanger maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and raises the price target from $4 to $5.

Heron Therapeutics: Q4 Earnings Insights
03/12/2024 20:50:06

Heron Therapeutics Sees FY24 Revenue $138M...
03/12/2024 20:30:49

Financial Guidance for 2024The Company reaffirms its full-year 2024 guidance for Product Revenues, Net, Adjusted Operating Expe...

Heron Therapeutics Q4 2023 Adj EPS $(0.07)...
03/12/2024 20:15:25

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Preview: Heron Therapeutics's Earnings
03/11/2024 15:01:17

why-blackberry-shares-are-trading-lower-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why BlackBerry Shares Are Trading Lower By...
01/24/2024 18:05:27

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private ...

heron-therapeutics-non-opioid-post-operative-pain-drug-approved-for-use-in-additional-orthopedic-soft-tissue-procedures---fda-gives-nod

Heron Therapeutics' Non-Opioid, Post-Opera...
01/24/2024 16:47:59

Zynrelef's expanded FDA approval for soft tissue and orthopedic surgeries, offering superior pain management with lower pai...

textron-posts-upbeat-earnings-joins-asml-progressive-and-other-big-stocks-moving-higher-on-wednesday

Textron Posts Upbeat Earnings, Joins ASML,...
01/24/2024 15:08:43

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Wednesday. Shares of Textron Inc. (NYSE: TX...